Biodexa Pharmaceticals (BDRX) Live Share Price, Invest From India

Biodexa Pharmaceticals Stock Performance

as on May 13, 2026 at 2:16 pm IST

Day's Low
Day's High
$3.69
Day's Price Range
$3.94
$3.80
2.89%
Downside
3.68%
Upside
52 Week's Low
52 Week's High
$2.86
52-Week Price Range
$96.50
$3.80
24.74%
Downside
2439.47%
Upside

Biodexa Pharmaceticals share price movements today

Previous Close: $3.68
Open: $3.75
Volume: 170.7K
Day's Low - High: $3.69 - $3.94
52 Week Low - High: $2.86 - $96.50

Biodexa Pharmaceticals Historical Returns

1 Month Return: + 22.58 %
3 Month Return: -29.63 %
1 Year Return: -94.11 %
3 Year Return: -99.98 %
5 Year Return: 0 %

Biodexa Pharmaceticals Stock Fundamentals & Key Indicators

Check Biodexa Pharmaceticals market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$2.4M

EPS (TTM)

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

EBITDA

-8.6M

Revenue (TTM)

83.0K

Profit Margin

0.00%

Return On Equity TTM

-64.72%

Biodexa Pharmaceticals vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Biodexa Pharmaceticals with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Biodexa Pharmaceticals	BUY	$2.4M	NA	NA	0.00%
Alnylam Pharmaceuticals Inc	BUY	$38.0B	119.7%	71.39	12.55%
BeiGene, Ltd.	NA	$32.7B	NA	71.44	8.94%
Vertex Pharmaceuticals Inc	BUY	$110.4B	109.14%	25.84	35.51%
Regeneron Pharmaceuticals Inc	BUY	$74.7B	39.88%	17.39	29.65%

Stock Returns calculator for Biodexa Pharmaceticals Stock including INR - Dollar returns

The Biodexa Pharmaceticals stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Biodexa Pharmaceticals investment value today

Current value as on today

₹6,612

Returns

-₹93,388

(-93.39%)

Returns from Biodexa Pharmaceticals Stock

-₹94,109 (-94.11%)

Dollar Impact

₹721 (+0.72%)

Analyst Recommendation on Biodexa Pharmaceticals Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Biodexa Pharmaceticals. Average target price of $36.03

Biodexa Pharmaceticals Share Price Target

Get share price movements and forecasts by analysts on Biodexa Pharmaceticals.

What analysts predicted

89.45%UPSIDE

Target Price

$36.03

Current Price

$3.8

Analyzed by

7 Analysts

Target

$36.03

Biodexa Pharmaceticals target price $36.03, a slight upside of 89.45% compared to current price of $3.8. According to 7 analysts rating.

Indian Investors' Interest in Biodexa Pharmaceticals Stock

Search interest for Biodexa Pharmaceticals Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Time period: April 13, 2026 to May 13, 2026

Change:-21% versus previous 30 day period

Biodexa Pharmaceticals Quarterly Profit & Loss

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023
Total Revenue	0	0	0	0	0
Gross Profit	-3	-1	-2	-1	-2
Operating Income	-3	-2	-4	-1	-3
EBITDA	-3	-2	-4	-1	-2
Interest Expense	-	-	-	-	-
Depreciation	-	-	-	-	-
Income Before Tax	-5	-1	-3	-1	-3
Income Tax Expense	0	0	0	0	0
Net Income	-5	-2	-4	-1	-3
Net Profit Margin	-1989.18%	-1197.32%	-1197.32%	-4230.12%	-4230.12%

Biodexa Pharmaceticals Annual Profit & Loss

All numbers in Millions USD

	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	1	0	1	0	0	0	0	0	-	-
Gross Profit	-6	-7	-7	-9	-7	-5	-5	-4	-6	0
Operating Income	-9	-11	-11	-11	-23	-6	-8	-8	-9	-8
EBITDA	-5	-10	-10	-9	-22	-5	-8	-7	-9	-8
Interest Expense	-	0	0	0	0	0	0	0	0	0
Depreciation	-	-	-	1	1	0	0	0	0	0
Income Before Tax	-8	-12	-12	-10	-23	-6	-8	-7	-5	-6
Income Tax Expense	-2	-1	-2	-1	-1	0	0	0	0	0
Net Income	-6	-11	-10	-13	-29	-7	-9	-8	-7	-6
Net Profit Margin	-465.68%	-1183.52%	-534.98%	-1496.29%	-6469.10%	-944.64%	-1095.28%	-1858.01%	0.00%	0.00%

Biodexa Pharmaceticals Quarterly Cash Flow

All numbers in Millions USD

	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Dec 2024	Jun 2025	Dec 2025
Net Income	-1	-3	-1	-3	-1	-3	-2	-3	-2
Operating Cash Flow	-1	-3	-1	-2	-2	-4	-7	-3	-2
Investing Cash Flow	0	0	-	0	-	0	0	0	0
Financing Cash Flow	3	6	1	3	2	4	3	6	7
Change in Cash	1	1	0	0	0	5	-5	4	4

Biodexa Pharmaceticals Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-16	-15	-10	-22	-5	-7	-7	-5	-6
Operating Cash Flow	-12	-13	-6	-9	-6	-7	-6	-12	-5
Investing Cash Flow	-1	9	-3	2	0	0	0	0	0
Financing Cash Flow	10	-6	18	3	8	0	10	8	12
Change in Cash	-4	-10	8	-3	2	-7	3	-4	6

Insights on Biodexa Pharmaceticals

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -3.80M → -2.56M (in $), with an average increase of 48.6% per quarter
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 41.5K → 83.0K (in $), with an average increase of 50.0% per quarter
NO EFFECT
Against Peers
In the last 1 year, BeOne Medicines Ltd has given 40.2% return, outperforming this stock by 134.3%
NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 32.2% return, outperforming this stock by 132.2%
NEGATIVE IMPACT
Price Dip
In the last 7 days, BDRX stock has moved down by -14.0%

About Biodexa Pharmaceticals

Biodexa Pharmaceuticals Plc, a clinical stage biopharmaceutical company, focuses on developing a pipeline of products for the treatment of familial adenomatous polyposis, non-muscle invasive bladder cancer, and Type 1 diabetes and rare/orphan brain cancer. Its lead product candidate, Tolimidone, is a selective activator of the lyn kinase enzyme, currently under Phase II studies for the treatment of Type 1 diabetes. The company is also developing MTX110, which is currently in Phase I studies for the treatment of recurrent glioblastoma, diffuse midline glioma, and medulloblastoma; and MTX240, for the treatment of gastrointestinal stromal tumors. In addition, the company offers drug delivery platforms, such as Q-Sphera, a polymer microsphere microtechnology used for sustained release therapeutics; MidaSolve, nanotechnology used to dissolve insoluble drugs so that they can be administered in liquid form directly and locally into tumours; and MidaCore, a gold nanoparticle used for targeting sites of disease. It has collaboration agreements with Janssen and Melior. The company was formerly known as Midatech Pharma plc and changed its name to Biodexa Pharmaceuticals Plc in March 2023. Biodexa Pharmaceuticals Plc was founded in 2000 and is headquartered in Cardiff, the United Kingdom.

Organisation	Biodexa Pharmaceticals
Headquarters	1 Caspian Point, Cardiff, United Kingdom, CF10 4DQ
Industry	Biotechnology
CEO	Mr. Stephen Anthony Stamp
E-voting on shares	Click here to vote

Key Management of Biodexa Pharmaceticals

Name	Title
Ms. Noreen Bhatti	Vice President of Clinical Operations
Mr. Stephen Anthony Stamp	CEO & Director
Ms. Fiona Mary Powell	Company Secretary, CFO & Director
Dr. Daniel Palmer MBA, Ph.D.	Vice President of Technology
Mr. Steve Ellul	Chief Business Officer
Dr. Gary A. Shangold CPI, FACOG, M.D.	Chief Medical Officer

FAQs

What is Biodexa Pharmaceticals share price today?

Biodexa Pharmaceticals share price today is $3.8 as on May 13, 2026 at 8:46 am IST at the close of the market. Biodexa Pharmaceticals share today touched a day high of $3.94 and a low of $3.69.

What is the 52 week high and 52 week low for Biodexa Pharmaceticals share?

Biodexa Pharmaceticals share touched a 52 week high of $96.5 on May 22, 2025 and a 52 week low of $2.86 on April 13, 2026. Biodexa Pharmaceticals stock price today i.e. May 13, 2026 at 8:46 am IST is closed at $3.8,which is 96.06% down from its 52 week high and 32.87% up from its 52 week low.

What is Biodexa Pharmaceticals's market capitalisation today?

Biodexa Pharmaceticals market capitalisation is $0.00T as on May 13, 2026 at 8:46 am IST.

How to invest in Biodexa Pharmaceticals Stock (BDRX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Biodexa Pharmaceticals on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Biodexa Pharmaceticals Shares that will get you 0.3947 shares as per Biodexa Pharmaceticals share price of $3.8 per share as on May 13, 2026 at 8:46 am IST.

What is the minimum amount required to buy Biodexa Pharmaceticals Stock (BDRX) from India?

Indian investors can start investing in Biodexa Pharmaceticals (BDRX) shares with as little as ₹95.705 or $1 (as of May 13, 2026 at 6:40 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Biodexa Pharmaceticals stock (as per the Rupee-Dollar exchange rate as on May 13, 2026 at 6:40 pm IST). Based on Biodexa Pharmaceticals share’s latest price of $3.8 as on May 13, 2026 at 8:46 am IST, you will get 2.6316 shares of Biodexa Pharmaceticals. Learn more about fractional shares .